Richard Miller
Directeur Général chez CORVUS PHARMACEUTICALS, INC.
Fortune : 3 M $ au 30/04/2024
Postes actifs de Richard Miller
Sociétés | Poste | Début | Fin |
---|---|---|---|
CORVUS PHARMACEUTICALS, INC. | Directeur Général | 01/02/2014 | - |
Président | 27/01/2014 | - | |
Fondateur | 27/01/2014 | - | |
President | 01/02/2014 | - | |
BOLT BIOTHERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/07/2017 | - |
Independent Dir/Board Member | 01/07/2017 | - | |
Angel Pharmaceuticals Co., Ltd.
Angel Pharmaceuticals Co., Ltd. BiotechnologyHealth Technology Angel Pharmaceuticals Co., Ltd. operates as a biopharmaceutical company which develops medicines for treatment of cancer, autoimmune and infectious diseases. The company was founded by Richard Miller and Ted Wang on October 5, 2020 and is headquartered in Shanghai, China. | Directeur Général | 05/10/2020 | - |
Président | 05/10/2020 | - | |
Fondateur | 05/10/2020 | - | |
BrainScope Co., Inc.
BrainScope Co., Inc. Medical SpecialtiesHealth Technology BrainScope Co., Inc. operates as a medical neurotechnology company which develops non-invasive tools. The firm focuses on optimizing analysis of brain electrical signals to enhance detection and assessment of changes in brain function. The company was founded by Elvir Causevic in 1990 and is headquartered in Bethesda, MD. | Directeur/Membre du Conseil | 01/10/2023 | - |
Historique de carrière de Richard Miller
Anciens postes connus de Richard Miller
Sociétés | Poste | Début | Fin |
---|---|---|---|
Graphea, Inc.
Graphea, Inc. Miscellaneous Commercial ServicesCommercial Services Graphea, Inc. engages in research and development in physical, engineering, and life sciences. The private company is based in Austin, TX. The company was founded by Richard A. Miller. | Directeur Général | 01/04/2012 | 01/10/2014 |
Président | 01/04/2012 | 01/10/2014 | |
Fondateur | 01/04/2012 | 01/10/2014 | |
President | 01/04/2012 | 01/10/2014 | |
The University of Texas at Austin | Corporate Officer/Principal | 01/09/2010 | 01/12/2011 |
PRINCIPIA BIOPHARMA INC. | Directeur/Membre du Conseil | 01/01/2009 | 01/02/2011 |
Directeur Général | 01/01/2009 | 01/02/2011 | |
Fondateur | 28/10/2008 | 01/02/2011 | |
President | 01/01/2009 | 01/02/2011 | |
PHARMACYCLICS, INC. | Directeur/Membre du Conseil | 01/04/1991 | 10/09/2008 |
Directeur Général | 01/04/1991 | 10/09/2008 | |
Fondateur | 01/04/1991 | 10/09/2008 | |
President | 01/04/1991 | 10/09/2008 | |
IDEC Pharmaceuticals Corp.
IDEC Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology IDEC Pharmaceuticals Corp. used to develop and commercialize targeted immunotherapies for the treatment of cancer and autoimmune diseases. The company’s products used to act chiefly through immune system mechanisms, exerting their effect by binding to specific, readily targeted immune cells in the patient’s blood or lymphatic system. The company was headquartered in San Diego, CA. | Directeur/Membre du Conseil | 01/01/1985 | 01/06/2003 |
Fondateur | 01/01/1985 | 01/06/2003 | |
Corporate Officer/Principal | 01/01/1985 | 01/06/2003 | |
░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░░░ | - | - | |
░░░░░░░░░░░░ ░░░░░░░░░░░ ░░░░ | ░░░░░░░ ░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░ ░░░░░░ ░░░░░░░░ | ░░░░░░░░░░ | - | |
░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | ░░░░░░░░░░ |
Formation de Richard Miller
Franklin & Marshall College | Undergraduate Degree |
The State University of New York | Doctorate Degree |
Statistiques
Internationale
Etats-Unis | 13 |
Chine | 2 |
Opérationnelle
Founder | 7 |
Director/Board Member | 6 |
Chief Executive Officer | 5 |
Sectorielle
Health Technology | 9 |
Consumer Services | 4 |
Finance | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 2 |
---|---|
CORVUS PHARMACEUTICALS, INC. | Health Technology |
BOLT BIOTHERAPEUTICS, INC. | Health Technology |
Entreprise privées | 8 |
---|---|
Pharmacyclics LLC
Pharmacyclics LLC Pharmaceuticals: MajorHealth Technology Pharmacyclics LLC engages in developing and commercializing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases. It has product candidates in clinical development and several preclinical molecules in optimization. The company was founded by Jonathan Sessler and Richard Miller in 1991 and is headquartered in Sunnyvale, CA. | Health Technology |
BrainScope Co., Inc.
BrainScope Co., Inc. Medical SpecialtiesHealth Technology BrainScope Co., Inc. operates as a medical neurotechnology company which develops non-invasive tools. The firm focuses on optimizing analysis of brain electrical signals to enhance detection and assessment of changes in brain function. The company was founded by Elvir Causevic in 1990 and is headquartered in Bethesda, MD. | Health Technology |
Principia Biopharma, Inc.
Principia Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Principia Biopharma, Inc. is a biopharmaceutical company, which engages in designing and developing oral therapies to patients with significant unmet medical needs in immunology and oncology. It operates through Tailored Covalency platform, which enables to develop small molecule inhibitors of enzymes and receptor ligands with potencies and selectivities that rival those of injectable biologics, yet maintain the convenience of a pill. Its product pipeline includes PRN1008, PRN2246, PRN1371, and immunoproteasome inhibitor. The company was founded by Jack Taunton and Richard A. Miller on October 6, 2008 and is headquartered in South San Francisco, CA. | Health Technology |
VantagePoint Management, Inc.
VantagePoint Management, Inc. Investment ManagersFinance VantagePoint Management, Inc. (VantagePoint) is a venture capital firm founded in 1996 by Alan Edward Salzman, James D. Marver. The firm is headquartered in Santa Barbara, California with additional office in Beijing, China. | Finance |
IDEC Pharmaceuticals Corp.
IDEC Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology IDEC Pharmaceuticals Corp. used to develop and commercialize targeted immunotherapies for the treatment of cancer and autoimmune diseases. The company’s products used to act chiefly through immune system mechanisms, exerting their effect by binding to specific, readily targeted immune cells in the patient’s blood or lymphatic system. The company was headquartered in San Diego, CA. | Health Technology |
CellPro, Inc. | Health Technology |
Graphea, Inc.
Graphea, Inc. Miscellaneous Commercial ServicesCommercial Services Graphea, Inc. engages in research and development in physical, engineering, and life sciences. The private company is based in Austin, TX. The company was founded by Richard A. Miller. | Commercial Services |
Angel Pharmaceuticals Co., Ltd.
Angel Pharmaceuticals Co., Ltd. BiotechnologyHealth Technology Angel Pharmaceuticals Co., Ltd. operates as a biopharmaceutical company which develops medicines for treatment of cancer, autoimmune and infectious diseases. The company was founded by Richard Miller and Ted Wang on October 5, 2020 and is headquartered in Shanghai, China. | Health Technology |
- Bourse
- Insiders
- Richard Miller
- Expérience